Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

Completed · Phase 2

Conditions studied: Lung Cancer

In brief

Open label study of sorafenib

Key facts

Study ID

NCT00456716

Run by

Swedish Medical Center

People needed

5

Starts

2007-03-01

Expected to finish

2008-12-01

Last updated by the study team

2010-03-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18
• Life expectancy > 12 weeks
• Biopsy-proven BAC or adenocarcinoma
• Willing to provide smoking status
• Selected IIIB or stage IV cancer that is incompletely resected or unresectable

You may not qualify if…

• O2 saturation < 88% on room air
• Pregnant or nursing women
• Surgery or radiation therapy within 4 weeks of starting study
• Major heart condition within 6 months of starting therapy
• Certain concomitant medications prohibited

Where it is running

• Swedish Cancer Institute — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.